Clinical Studies - Gamma Scintigraphy

Gamma scintigraphy studies have confirmed Controlled Particle Dispersion’s unique ability to saturate the entire nasal cavity, including the olfactory regions and the paranasal sinuses. Studies showed the average area of intranasal distribution was as much as 300 percent greater for Kurve’s ViaNaseTM device compared to traditional spray bottles. In all cases, ViaNase demonstrated a greater propensity for delivery of droplets to the paranasal sinuses than current methods.

"View a scintigraphy study that compares
Kurve’s ViaNase device to spray pumps."

Deposition Comparison - A Scintigraphic Study

  Home | Nasal Drug Delivery | Technology | Clinical Studies | Devices | Investors | News & Events | About Kurve | Contact

Copyright 2017, Kurve Technology, Inc. All Rights Reserved | Site Map
Technology Marketing